Clinical Case Reports (Dec 2022)

COVID‐associated non‐vasculitic thrombotic retiform purpura of the face and extremities: A case report

  • Connor M. Bunch,
  • Nuha Zackariya,
  • Anthony V. Thomas,
  • Jack H. Langford,
  • Michael Aboukhaled,
  • Samuel J. Thomas,
  • Aida Ansari,
  • Shivani S. Patel,
  • Hallie Buckner,
  • Joseph B. Miller,
  • Christy L. Annis,
  • Margaret A. Quate‐Operacz,
  • Leslie A. Schmitz,
  • Joseph J. Pulvirenti,
  • Jonathan C. Konopinski,
  • Kathleen M. Kelley,
  • Samer Hassna,
  • Luke G. Nelligan,
  • Mark M. Walsh

DOI
https://doi.org/10.1002/ccr3.6790
Journal volume & issue
Vol. 10, no. 12
pp. n/a – n/a

Abstract

Read online

Abstract SARS‐CoV‐2 infection can manifest many rashes. However, thrombotic retiform purpura rarely occurs during COVID‐19 illness. Aggressive anti‐COVID‐19 therapy with a high‐dose steroid regimen led to rapid recovery. This immunothrombotic phenomenon likely represents a poor type 1 interferon response and complement activation on the endothelial surface in response to acute infection.

Keywords